Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Alexandros, Ioannou"'
Autor:
Kanellos Koustenis, Nikolas Dovrolis, Nikos Viazis, Alexandros Ioannou, Giorgos Bamias, George Karamanolis, Maria Gazouli
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 10, p 5532 (2024)
Introduction: Optimizing treatment with biological agents is an ideal goal for patients with ulcerative colitis (UC). Recent data suggest that mucosal inflammation patterns and serum cytokine profiles differ between patients who respond and those who
Externí odkaz:
https://doaj.org/article/ba38663c639240a58a651e6d4b6c4a8f
Autor:
Georgios Axiaris, Leonidas Marinos, Marina Papoutsaki, Alexandros Ioannou, Spyridon Michopoulos, Michael Liontos, Evanthia Zampeli
Publikováno v:
F1000Research, Vol 11 (2023)
The cornerstone of inflammatory bowel disease (IBD) treatment is immunomodulators. IBD patients are at increased risk of intestinal and extraintestinal malignancy. Ustekinumab is a fully humanized monoclonal anti-IL12/23 antibody with a good safety p
Externí odkaz:
https://doaj.org/article/66d3a7c1fb264e4f8224e8908583cd50
Autor:
Alexandros Ioannou, Georgios Papaxoinis, Dimitrios Dimitroulopoulos, Dimitrios Tryfonopoulos, Panagiotis Gouveris
Publikováno v:
Forum of Clinical Oncology, Vol 12, Iss 3, Pp 28-33 (2022)
Cancer immunotherapy is an emerging beneficial treatment for cancer that acts by activating the immune system to produce antitumour effects. In particular, immune checkpoint therapy has recently provided novel strategies for cancer treatments. Nevert
Externí odkaz:
https://doaj.org/article/1e1379852e644e1a817bbbdbf8316d50
Autor:
Eleni Manthopoulou, Daryl Ramai, Jahnvi Dhar, Jayanta Samanta, Alexandros Ioannou, Ekaterina Lusina, Rodolfo Sacco, Antonio Facciorusso
Publikováno v:
Vaccines, Vol 11, Iss 6, p 1062 (2023)
Cholangiocarcinoma (CCA) is a rare malignancy of the gastrointestinal tract, with aggressive behavior, and portends a poor prognosis. Traditionally, it is classified according to its site of involvement as intrahepatic, perihilar, and distal cholangi
Externí odkaz:
https://doaj.org/article/6b2c5ab9d37246f08505ec83c71330ac
Publikováno v:
Children, Vol 10, Iss 4, p 692 (2023)
Boys with valve bladder syndrome (PUV) require adequate treatment of the lower urinary tract to preserve renal function and improve long-term outcomes. In some patients, further surgery may be necessary to improve bladder capacity and function. Urete
Externí odkaz:
https://doaj.org/article/024cfa6d92ca4cd29888c6b005a29355
Autor:
Alessandro Zanasi, Antonio M. Morselli-Labate, Massimiliano Mazzolini, Marianna Mastroroberto, Roberto W. Dal Negro, Ivan Poliacek, Alyn H. Morice, Sara Maio, Giovanni Viegi, Jamie Koufman, Francesco Torresan, Alexandros Ioannou, Daniele Mandolesi, Elisa Liverani, Amedeo Montale, Franco Bazzoli, Fabio Baldi, Maurizio Zompatori, Giovanni A. Fontana, Ahmad Kantar, Peter Dicpinigaitis, Clive Page, Surinder S. Birring, Francesco Tursi
Publikováno v:
Multidisciplinary Respiratory Medicine, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract This paper summarizes the presentations submitted for publication of the 12th AIST National Congress (Associazione Italiana Studio Tosse/Italian Association for Cough Study) entitled “The thousand facets of cough. A clinical and therapeuti
Externí odkaz:
https://doaj.org/article/d92f461bc92e4231b93b2876052984bd
Autor:
Alexandros, Ioannou1 (AUTHOR) alexandros.ioannou@studio.unibo.it, Georgios, Papaxoinis2 (AUTHOR), Dimitrios, Dimitroulopoulos1 (AUTHOR), Dimitrios, Tryfonopoulos2 (AUTHOR), Panagiotis, Gouveris2 (AUTHOR)
Publikováno v:
Forum of Clinical Oncology. Dec2021, Vol. 12 Issue 3, p28-33. 6p.
Autor:
Spyridon Michopoulos, Georgios Axiaris, Alexandros Ioannou, Evgenia Papathanasiou, Mary Tzakri, Georgios Leonidakis, Evanthia Zampeli, Panagiotis Baxevanis, Kalliopi Petraki
Publikováno v:
Gastrointestinal Endoscopy. 95:AB368
Autor:
Spyridon Michopoulos, Georgios Axiaris, Alexandros Ioannou, Evgenia Papathanasiou, Mary Tzakri, Georgios Leonidakis, Evanthia Zampeli, Dimitrios Valsamidis
Publikováno v:
Gastroenterology. 162:S-469
Autor:
Georgios Axiaris, Alexandros Ioannou, Marina Papoutsaki, Leonidas Marinos, Michael Liontos, Spyridon Michopoulos, Evanthia Zampeli
Publikováno v:
F1000Research. 11:424
The cornerstone of inflammatory bowel disease (IBD) treatment is immunomodulators. IBD patients are at increased risk of intestinal and extraintestinal malignancy. Ustekinumab is a fully humanized monoclonal anti-IL12/23 antibody with a good safety p